Mark G Faber (Mark Faber)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Chemotherapy Induced

Neuroendocrine Tumors

Acute Lymphoblastic Leukemia

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire, Mark G Faber, Rahul S Vedula, Anne Charles, Kevin M Copson, Shai Shimony, Alon Rozental, Pavan K Bendapudi, Ofir Wolach, Elizabeth A Griffiths, James E Thompson, Richard M Stone, Daniel J DeAngelo, Donna Neuberg, Marlise R Luskin, Eunice S Wang, R Coleman Lindsley
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood advances 6 (9) (2022)
Abhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths, Alaa Altahan, Mahesh Swaminathan, Medhavi Gupta, Matthew Gravina, Rutaba Tajammal, Mark G Faber, LunBiao Yan, Eti Sinha, Duane C Hassane, David Neil Hayes, Monica L Guzman, Renuka Iyer, Eunice S Wang, Swapna Thota
Mutant PPM1D - and TP53 -Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy. JCO precision oncology 6 (2022)
Mark G Faber, David R Lloyd, Abhay Singh, Jeffrey Baron, Amanda Przespolewski, Elizabeth A Griffiths, Eunice S Wang, Swapna Thota
Predictors of vascular disease in myelodysplastic syndromes. EJHaem 1 (2) (2020)